Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DoubleTree Bethesdan

Sep 19, 2019 7:00 AM - Sep 20, 2019 3:15 PM

8120 Wisconsin Avenue, , Bethesda, MD 20814 , USA

Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest global requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Session 9: Protecting Confidential Information in Summaries of Trial Results

Session Chair(s)

Robert  Paarlberg, MS

Robert Paarlberg, MS


United States

Global clinical data disclosure and transparency requirements and initiatives have resulted in massive amounts of clinical data in the public domain. Local county and regional data protection regulations safe guard personal identifiable information from public disclosure. This session will explore how patient identifiable data are being protected in this global clinical disclosure/transparency ecosystem.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss the interplay between disclosure/transparency requirements and country/regional data protection regulations
  • Identify stakeholder perspectives
  • Implement best practices


Behtash  Bahador, MS

Protecting Confidentiality: Public and Patient Perceptions and Best Communication Practice: Behtash Bahador, MS

Director, Health Literacy

Center for Information and Study on Clinical Research Participation (CISCRP), United States

Michael A. DiMaio, JD

Common Challenges Under GDPR for Data Disclosure and Transparency: Michael A. DiMaio, JD


Ropes & Gray LLP, United States

Brendan  Barnes

Anonymisation and Public Trust (Remote Presentation): Brendan Barnes

Director, Data Protection & IP

EFPIA, Belgium

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.